How DexCom Leverages AI To Tackle Diabetes
Published August 08, 2025

Editor in Chief of Constellation Insights
Executive Summary
Dexcom, which makes glucose monitoring equipment and technology, is betting that it can dramatically expand its total addressable market for people with diabetes with a big assist from generative artificial intelligence (GenAI).
--- OR ---
Purchase this single report
$2,035.00
Related Research
Results
Research Product
Customer StoryPublished
August 08, 2025Author
Categories
Data to Decisions
Digital Safety, Privacy & Cybersecurity
Future of Work
Innovation & Product-led Growth
Marketing Transformation
Matrix Commerce
New C-Suite
Next-Generation Customer Experience
Tech Optimization
Chief Analytics Officer
Chief Customer Officer
Chief Data Officer
Chief Digital Officer
Chief Executive Officer
Chief Financial Officer
Chief Information Officer
Chief Privacy Officer
Chief Technology Officer